EXHIBIT 3
JOINT FILING AGREEMENT
This will confirm the agreement by and between the undersigned that the
Statement on Schedule 13D (the "Statement") filed on or about this date, and all
amendments thereto, relating to the offer by SHL TeleMedicine Acquisition Corp.,
a Delaware corporation ("Purchaser") and an indirect wholly-owned subsidiary of
SHL TeleMedicine Ltd., an Israeli corporation ("SHL"), to purchase all the
outstanding shares of common stock, par value $0.001 per share, of Raytel
Medical Corporation, a Delaware corporation ("Raytel"), including the associated
rights to purchase the Series A Preferred Stock of Raytel, are being filed on
behalf of the undersigned and the agreement that SHL may make such filings on
behalf of Purchaser.
Each of the undersigned hereby acknowledges that pursuant to Rule 13d-1(k)
promulgated under the Securities Exchange Act of 1934, as amended, that each
person on whose behalf the Statement is filed is responsible for the timely
filing of such statement and any amendments thereto, and for the completeness
and accuracy of the information concerning such person contained therein; and
that such person is not responsible for the completeness or accuracy of the
information concerning the other persons making the filing, unless such person
knows or has reason to believe that such information is inaccurate.
This Agreement may be executed in two or more counterparts by each of the
undersigned, and each of which, taken together, shall constitute one and the
same instrument.
Date: February 19, 2002
SHL TELEMEDICINE LTD.
By: /s/ Xxxxx Xxxxx
-----------------------------------
Name: Xxxxx Xxxxx
Title Co-President
SHL TELEMEDICINE ACQUISITION CORP.
By: /s/ Xxxxx Xxxxx
-----------------------------------
Name: Xxxxx Xxxxx
Title Co-President
